Pharma Sourcing Playbook: Wallet Share Analysis of Top 20 Pharma

Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise spend, creating concentrated portfolios with limited diversification beyond core partners. This concentration introduces both operational efficiencies and risks related to provider leverage, pricing, and innovation dependency.

The report provides a detailed view of wallet share distribution among leading Global System Integrators (GSIs) across the top 20 pharma enterprises. It presents an enterprise lens, highlighting how spend is distributed across the leading GSIs and the resulting strategic implications for sourcing optimization. It also includes a provider lens, examining GSI penetration, the role of other providers, peer-to-peer competitive dynamics, and targeted recommendations for providers to expand their presence and influence within strategic accounts.